Northwire Canada EditionTuesday, July 14, 2026
Sign inSubscribe
Northwire
⌕
ROCK 3.81 +3.0% APMI 0.120 +0.0% EM 3.58 −4.8% ALS 66.04 +6.8% MEK 0.065 +44.4% TLO 6.00 +13.0% ADE 0.045 −66.7% FAIR 0.060 +33.3% SVRS 0.420 −2.3% RES 0.050 +42.9% CYG 0.120 +0.0% MGG 0.310 −6.1% BUFF 0.770 +2.7% TKO 11.18 +12.2% MINK 0.105 +0.0% ROCK 3.81 +3.0% APMI 0.120 +0.0% EM 3.58 −4.8% ALS 66.04 +6.8% MEK 0.065 +44.4% TLO 6.00 +13.0% ADE 0.045 −66.7% FAIR 0.060 +33.3% SVRS 0.420 −2.3% RES 0.050 +42.9% CYG 0.120 +0.0% MGG 0.310 −6.1% BUFF 0.770 +2.7% TKO 11.18 +12.2% MINK 0.105 +0.0%

← Back to our analysis

Original News Release

Doseology closes acquisition of Feed That Brain unit

Doseology Sciences Inc Aug 27, 2025 · 14:41 MOOD As distributed — unedited
Mr. Chris Jackson reports DOSEOLOGY COMPLETES ACQUISITION OF FEED THAT BRAIN(TM) Further to Doseology Sciences Inc.'s news release of Aug. 19, 2025, it has closed the acquisition of the Feed That Brain division operated by Joseph Mimran & Associates Inc. (the vendor) and has completed the issuance to the vendor of 175,000 common shares at a deemed price of $1.00 per share, satisfying the first payment required pursuant to the asset purchase and sale agreement executed between the parties. The shares issued to the vendor are subject to a four-month hold period in accordance with securities laws in Canada. About Doseology Sciences Inc. Doseology is a biotech innovation company, engineering precision-formulated oral stimulants that optimize energy, focus and cognitive performance. Through rigorous scientific research and advanced delivery technologies, the company is pioneering next-gen performance solutions designed to empower peak performance. We seek Safe Harbor.
View at source ↗